JESSICA KNAPMEYER: Open Payments
NPI 1861137812 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,676 in 99 payments from 20 companies in 2025. Trend: 2023 $486 · 2024 $1,408 · 2025 $1,676
Food & beverage: $1,676
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $237 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $137 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Axsome Therapeutics, Inc. | 5 | $99 |
| Exact Sciences Corporation | 5 | $97 |
| Lilly USA, LLC | 5 | $90 |
| PFIZER INC. | 5 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, Cologuard Collection Kit, XIFAXAN, NURTEC ODT, RELISTOR.
Industry payments across AL — which companies pay providers there.
